Concepedia

Eftathios Kastritis

EK

Statistics

Publications

4

Citations

113

H-Index

4

Active since

2018

Affiliations

National and Kapodistrian University of Athens(Current)

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Arizona

Tufts Medical Center

University of Pavia

Eftathios Kastritis is an author at National and Kapodistrian University of Athens specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

2018–2019

4

Publications

4

Primary Results from the Phase 3 Tourmaline-AL1 Trial of Ixazomib-Dexamethasone Versus Physician's Choice of Therapy in Patients (Pts) with Relapsed/Refractory Primary Systemic AL Amyloidosis (RRAL)

Angela Dispenzieri, Eftathios Kastritis, Ashutosh Wechalekar et al. · Blood · 2019 · 39 citations

, , +4

Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage IV Patients

Morie A. Gertz, Adam D. Cohen, Raymond L. Comenzo et al. · Blood · 2019 · 38 citations

, , +11

Ibrutinib Treatment in Waldenström's Macroglobulinemia: Follow-up Efficacy and Safety from the iNNOVATETM Study

Christian Buske, Alessandra Tedeschi, Judith Trotman et al. · Blood · 2018 · 24 citations

, , +5

Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial

Marie José Kersten, Monique C. Minnema, Josephine M. I. Vos et al. · Blood · 2019 · 12 citations

, , +9

1–4 of 4